Mariana Oncology

Risk score

57
Large logo of Mariana Oncology

Headquarters

Flag of United States of AmericaUnited States of America

Mariana Oncology is an entirely integrated, advanced radiopharmaceuticals corporation specializing in pioneering a novel category of focused peptide-based radiopharmaceuticals. The firm's radiopharmaceuticals consist of thoughtfully designed compounds targeting specifically chosen biological receptors to transport alpha or beta-emitting radionuclide cargoes. Through the development of molecules engineered to infiltrate solid tumors more effectively than antibodies and provide maximized high radiation activity doses without the adverse effects linked to chemotherapy and toxin-oriented approaches, Mariana Oncology is striving to revolutionize cancer treatment.